HF
CORZW

HRT Financial’s Core Scientific, Inc. Warrant CORZW Stock Holding History

HRT Financial’s Portfolio CORZW Stock Details CORZW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,936
Closed -$26K – 4028
2022
Q1 		$26K Buy
+13,936
New +$32.7K ﹤0.01% 2808

Other funds holding CORZW

MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $561M AUM 283.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
GAMA
Graticule Asia Macro Advisors New York $1.33B AUM 1,044.61% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
CCM
Cinctive Capital Management New York $2.72B AUM 43.27% 1-Year Est. Return

HRT Financial's CORZW Position: Q2 2022 in Review

HRT Financial sold out of Core Scientific, Inc. Warrant (CORZW) in Q2 2022, closing a stake of 13,936 shares — an estimated $26K sold.

HRT Financial first reported a position in CORZW in Q1 2022 and held it in 1 quarter. The position peaked at $26K in Q1 2022. 20 funds tracked by Wall St. Rank hold CORZW as of Q2 2022.

  • HRT Financial reported no remaining Core Scientific, Inc. Warrant position as of Q2 2022 after selling out during the quarter.
  • HRT Financial sold 13,936 Core Scientific, Inc. Warrant shares in Q2 2022, an estimated $26K.
  • HRT Financial first reported a position in Core Scientific, Inc. Warrant in Q1 2022 and held it in 1 quarter.
  • HRT Financial's Core Scientific, Inc. Warrant position peaked at $26K in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Core Scientific, Inc. Warrant as of Q2 2022.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.